Therapeutic Advances in Psychopharmacology

Papers
(The H4-Index of Therapeutic Advances in Psychopharmacology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness39
History repeating: guidelines to address common problems in psychedelic science28
Risperidone-induced neuroleptic malignant syndrome: a case report26
Tardive dyskinesia: understanding current challenges in diagnosis and treatment24
Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study24
Increased amisulpride serum concentration in a patient treated with concomitant pregabalin and trazodone: a case report23
Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years’ experience at a UK high-secure hospital20
Metformin co-commencement at time of antipsychotic initiation for attenuation of weight gain: a systematic review and meta-analysis20
Drug safety in older patients with alcohol use disorder: a retrospective cohort study20
Antipsychotic polypharmacy and clozapine prescribing patterns: evolution and correlates before and after a psychiatric hospitalisation18
Exploring the clinical factors affecting lithium dose and plasma level and the effect of brand16
Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation16
Will psilocybin lose its magic in the clinical setting?14
0.083415985107422